Related content

Double-blind, placebo-controlled cross-over study of oral pilocarpine for the prevention of chemotherapy-induced oral mucositis in adult patients with cancer

By Awidi A.   Homsi U.   Kakail R.I.   Mubarak A.   Hassan A.   Kelta M.   Martinez P.   Sulaiti S.   Al Qady A.   Jamhoury A.   Daniel M.   Charles C.   Ambrose A.   El-Aloosy A.S.  

European Journal of Cancer, Vol. 37, Iss. 16, 2001-11 ,pp. : 2010-2014

Elsevier

Access to resources Recommend Favorite

A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Dose-Finding Study of ORG 2766 in the Prevention or Delay of Cisplatin-Induced Neuropathies in Women with Ovarian Cancer

By Roberts J.A.   Jenison E.L.   Kim K.   Clarke-Pearson D.   Langleben A.  

Gynecologic Oncology, Vol. 67, Iss. 2, 1997-11 ,pp. : 172-177

Elsevier

Access to resources Recommend Favorite

L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: A double-blind, randomized, placebo-controlled trial

By  

Oncology Reports, Vol. 33, Iss. 1, 2015-01 ,pp. : 33-39

Spandidos Publications

Access to resources Recommend Favorite

Erythropoietin Treatment under Polychemotherapy in Patients with Gynecologic Malignancies: A Prospective, Randomized, Double-Blind Placebo-Controlled Multicenter Study

By Kurz C.   Marth C.   Windbichler G.   Lahousen M.   Medl M.   Vavra N.   Sevelda P.  

Gynecologic Oncology, Vol. 65, Iss. 3, 1997-06 ,pp. : 461-466

Elsevier

Access to resources Recommend Favorite

A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation

By Schubert Mark  

Supportive Care in Cancer, Vol. 15, Iss. 10, 2007-10 ,pp. : 1145-1154

Springer Publishing Company

Access to resources Recommend Favorite